| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9532 |
| Human Intestinal Absorption | HIA+ | 1.0000 |
| Caco-2 Permeability | Caco2- | 0.5260 |
| P-glycoprotein Substrate | Non-substrate | 0.7887 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.6531 |
| Non-inhibitor | 0.9206 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.9205 |
| Distribution |
| Subcellular localization | Mitochondria | 0.5617 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8220 |
| CYP450 2D6 Substrate | Non-substrate | 0.8344 |
| CYP450 3A4 Substrate | Non-substrate | 0.5894 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.7956 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.7330 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9025 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.7412 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.8309 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.7246 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.8881 |
| Non-inhibitor | 0.9003 |
| AMES Toxicity | Non AMES toxic | 0.9459 |
| Carcinogens | Carcinogens | 0.7708 |
| Fish Toxicity | High FHMT | 0.9172 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.8264 |
| Honey Bee Toxicity | High HBT | 0.9484 |
| Biodegradation | Not ready biodegradable | 0.9665 |
| Acute Oral Toxicity | I | 0.7824 |
| Carcinogenicity (Three-class) | Non-required | 0.6169 |